Institutional members access full text with Ovid®

Share this article on:

Low Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Nuuk, Greenland

Pedersen, Michael Lynge MD, PhD*†; Clausen-Dichow, Pernille MD; Poulsen, Peter; Nyborg, Hanne RN; Jensen, Jørgen Skov MD, PhD, DMedSci§

doi: 10.1097/01.OLQ.0000430780.79488.0f

During a 35-day period, 32 isolates of Neisseria gonorrhoeae strains were collected by culture from patients with positive nucleic acid amplification test results in Nuuk, Greenland, where ciprofloxacin is the preferred treatment. All isolates were quinolone susceptible, suggesting that resistance is rare. Sampling patients for culture before treatment may prove useful in reestablishing surveillance.

Antimicrobial susceptibility testing is lacking in Greenland because of nucleic acid amplification test for Neisseria gonorrhoeae, but ciprofloxacin has remained the recommended treatment. A survey suggested that quinolone resistance is rare and proposed a method for surveillance.

From the *Greenland Center for Health Research, Nuuk, Greenland; ‡Queen Ingrid Hospital, Nuuk, Greenland; †Queen Ingrid Health Care Centre, Nuuk, Greenland; and §Statens Serum Institut, Copenhagen, Denmark

Competing interest: None declared.

Correspondence: Michael Lynge Pedersen, MD, PhD, Queen Ingrid Health Care Center, Box 3333, 3900 Nuuk, Greenland. E-mail:

Received for publication January 10, 2013; and accepted April 11, 2013.

© Copyright 2013 American Sexually Transmitted Diseases Association